Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015
Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Dominique Farge(Hôpital Saint-Louis), Andrew R. Gennery(Newcastle upon Tyne Hospitals NHS Foundation Trust), Christina Peters(Cancer Research Institute of the Slovak Academy of Sciences), J. Alejandro Madrigal(Royal Free London NHS Foundation Trust), Simone Cesaro(Azienda Ospedaliera Universitaria Integrata Verona), Mohamad Mohty(Sorbonne Université), Francesco Lanza(Ospedale "Santa Maria delle Croci" di Ravenna), Peter Bader(Goethe University Frankfurt), J.H. Frederik Falkenburg(Leiden University Medical Center), Arnon Nagler(Sheba Medical Center), Andrea Velardi(University Niccolò Cusano), Rafael F. Duarte(Institut Català d'Oncologia), Carlo Dufour(Istituto Giannina Gaslini), Peter Dreger(Heidelberg University), Nicolaus Kröger(Universität Hamburg), James C. Marsh(King's College London)
Cited by 337
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k